Juan M. Mucci

La Plata, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology.

Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology.

Journal: International journal of molecular sciences

Published: May 18, 2023

Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease.

Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease.

Journal: Molecular genetics and metabolism reports

Published: May 15, 2023

Corrigendum to "Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis" [Molecular Genetics Metabolism 130 (2020) 274-282].

Corrigendum to "Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis" [Molecular Genetics Metabolism 130 (2020) 274-282].

Journal: Molecular genetics and metabolism

Published: August 01, 2020

Unraveling the mystery of Gaucher bone density pathophysiology.

Unraveling the mystery of Gaucher bone density pathophysiology.

Journal: Molecular genetics and metabolism

Published: June 18, 2020

Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis.

Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis.

Journal: Molecular genetics and metabolism

Published: April 14, 2020

Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease.

Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease.

Journal: PloS one

Published: March 08, 2019

In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase.

In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase.

Journal: Bone

Published: January 31, 2017

Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.

Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.

Journal: International journal of molecular sciences

Published: October 17, 2016

Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology.

Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology.

Journal: Blood cells, molecules & diseases

Published: December 11, 2014

Pathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System.

Pathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System.

Journal: Journal of immunology research

Published: October 08, 2014

Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.

Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.

Journal: Gene

Published: August 08, 2013

Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide.

Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide.

Journal: Molecular genetics and metabolism

Published: February 04, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026